Nexgel’s Celularity Deal: Execution, Integration, and Profitability Risks from $13.3 Million Biomaterials Acquisition
Celularity risks Nasdaq delisting after CELU bid price stays below $1 for 30 days
12 Health Care Stocks Moving In Monday's After-Market Session
Celularity Secures Insider-Backed Short-Term Loan Facility
Celularity appoints Steven N. Gordon as COO and K. Harold Fletcher as CLO & Corporate Secretary
Celularity names Steven Gordon chief operating and administrative officer